Sex differences in expression and differential regulation by androgen and estrogen of two odorant-binding tear lipocalins in lacrimal glands of immature hamsters.
In adults of several mammalian species, lacrimal glands (LG) have sex differences but there is no report of any sexual dimorphism in LG of immatures. In LG and tears of adult hamsters, we found female-specific expression of two closely related odorant-/pheromone-binding lipocalins, FLP (female lacrimal protein) and MSP (male-specific protein; initially identified in salivary glands of males). Although, both androgens and estrogens markedly repress FLP and MSP in LG of adults, the expression of these lipocalins in females is due to their incomplete repression by endogenous estrogens. Here we report a marked sexual dimorphism in the expression of FLP and MSP in LG and tears of 20-day-old immature hamsters. The age-dependant expression of these lipocalins and effect of neonatal-gonadectomy and sex hormone treatments on their expression in immatures was investigated. FLP and MSP are detectable in LG at 10-day age in both sexes of hamster but by 20-day age levels of both lipocalins show sex differences wherein FLP is several fold higher in males and MSP is obliterated in males. Thereafter, FLP declines in male LG and is obliterated by 36-day age, resulting in female-specific expression of both LG lipocalins as seen in adults. In LG of 20-day-old immatures, FLP and MSP are insensitive to repression by androgen and estrogen, respectively, which was unlike the androgen/estrogen-repressed regulation of both lipocalins in adult LG. The estrogenic repression of FLP and androgenic repression of MSP in LG of immature hamsters could be prevented by treatment with tamoxifen and flutamide, respectively. Our studies indicate that (i) presence of gonads in immatures can have significant effects on LG lipocalins resulting in their sexually dimorphic expression, (ii) in immatures, unlike adults, the repressive effects of estrogen and androgen on LG lipocalins are selective for FLP and MSP, respectively, and (iii) these repressions are likely to be mediated by sex hormone receptors.
Srikantan
Subramanya
S
Centre for Cellular and Molecular Biology, Uppal Road, Hyderabad, Andhra Pradesh, India.
De
Prabir K
PK
D000367:Age Factors; D000726:Androgen Antagonists / Q000494:pharmacology; D059002:Androgen Receptor Antagonists; D000728:Androgens / Q000494:pharmacology*; D000818:Animals; D000831:Animals, Newborn; D015153:Blotting, Western; D006224:Cricetinae; D004965:Estrogen Antagonists / Q000494:pharmacology; D004967:Estrogens / Q000494:pharmacology*; D005260:Female; D005485:Flutamide / Q000494:pharmacology; D007765:Lacrimal Apparatus / Q000187:drug effects* / Q000378:metabolism; D054835:Lipocalin 1 / Q000378:metabolism*; D008297:Male; D051379:Mice; D051381:Rats; D011960:Receptors, Estrogen / Q000037:antagonists & inhibitors; D018035:Receptors, Odorant / Q000378:metabolism*; D012737:Sex Factors; D013629:Tamoxifen / Q000494:pharmacology
D000726:Androgen Antagonists; D059002:Androgen Receptor Antagonists; D000728:Androgens; D004965:Estrogen Antagonists; D004967:Estrogens; D054835:Lipocalin 1; D011960:Receptors, Estrogen; D018035:Receptors, Odorant; C045648:odorant-binding protein; D013629:Tamoxifen; D005485:Flutamide